Evidence map›Paper›PMID 27477910›Full record

ArticleMolecular cell2016

DNA Breaks and End Resection Measured Genome-wide by End Sequencing.

Andres Canela, Sriram Sridharan, Nicholas Sciascia, Anthony Tubbs, Paul Meltzer, Barry P Sleckman, André Nussenzweig

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 194 papers.

0numbers the graph read from it
0cells of the map it votes in
194citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

194 citing papers in PubMed, 292 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

134 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andres CanelaLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Sriram SridharanLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Nicholas SciasciaLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Anthony TubbsLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Paul MeltzerGenetics Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Barry P SleckmanDepartment of Pathology and Laboratory Medicine, Weil Cornell Medical College, New York, NY 10065, USA.
André NussenzweigLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Electronic address: andre_nussenzweig@nih.gov.
National Cancer Institute · USCornell University · US

Funding

DNA RepairZIABC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Relationship between DNA damage detection and signalingZIABC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Cancer Genomics Technology DevelopmentZIABC011091 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MELTZER, PAUL S. · 2009 to 2025
$16.9M
ATM FUNCTION DURING V(D)J RECOMBINATIONR01AI074953 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2009 to 2023
$5.9M
DNA REPAIRZ01BC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 1998 to 2008
$2.9M
Relationship between DNA damage detection and signalingZ01BC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2008 to 2008
$812k
Intramural NIH HHS Z01 BC010283Intramural NIH HHS Z01 BC010959NIAID NIH HHS R01 AI074953
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) arise during physiological transcription, DNA replication, and antigen receptor diversification. Mistargeting or misprocessing of DSBs can result in pathological structural variation and mutation. Here we describe a sensitive method (END-seq) to monitor DNA end resection and DSBs genome-wide at base-pair resolution in vivo. We utilized END-seq to determine the frequency and spectrum of restriction-enzyme-, zinc-finger-nuclease-, and RAG-induced DSBs. Beyond sequence preference, chromatin features dictate the repertoire of these genome-modifying enzymes. END-seq can detect at least one DSB per cell among 10,000 cells not harboring DSBs, and we estimate that up to one out of 60 cells contains off-target RAG cleavage. In addition to site-specific cleavage, we detect DSBs distributed over extended regions during immunoglobulin class-switch recombination. Thus, END-seq provides a snapshot of DNA ends genome-wide, which can be utilized for understanding genome-editing specificities and the influence of chromatin on DSB pathway choice.

Indexed as

DNA Breaks, Double-StrandedGenomeAnimalsAtaxia Telangiectasia Mutated ProteinsB-LymphocytesChromatinDNADNA-Binding ProteinsDNA ReplicationGene Expression RegulationHigh-Throughput Nucleotide SequencingHistonesImmunoglobulin Class SwitchingMicePrecursor Cells, B-LymphoidReceptors, Antigen, T-Cell, alpha-betaAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseChromatinDNADNA-Binding ProteinsHistonesRag2 protein, mouseReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID27477910
PMCPMC6299834
OpenAlexW2495544654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.